C57BL/6N-Atm1Brd Cdkal1tm2a(EUCOMM)Wtsi/WtsiCnbc
Status | Available to order |
EMMA ID | EM:06264 |
International strain name | C57BL/6N-Atm1Brd Cdkal1tm2a(EUCOMM)Wtsi/WtsiCnbc |
Alternative name | EPD0635_1_G08 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Cdkal1tm2a(EUCOMM)Wtsi |
Gene/Transgene symbol | Cdkal1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0635_1_G08. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Animals used for archiving | heterozygous C57BL/6NCrl |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- decreased body weight / MGI
- abnormal glucose homeostasis / MGI
- no abnormal phenotype detected / MGI
- decreased circulating insulin level / MGI
- decreased insulin secretion / MGI
- increased triglyceride level / MGI
- decreased triglyceride level / MGI
- decreased circulating glucose level / MGI
- abnormal cell physiology / MGI
- increased circulating leptin level / MGI
- decreased subcutaneous adipose tissue amount / MGI
- decreased abdominal fat pad weight / MGI
- increased liver triglyceride level / MGI
- decreased liver triglyceride level / MGI
- decreased food intake / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).